National Drug Control Strategy: Counterdrug Research and Development Blueprint Update (February 2002) [open pdf - 1MB]
This Counterdrug Research and Development Blueprint Update provides a periodic report on the counterdrug research and development (R&D) program. The report concentrates on those accomplishments made with CTAC-sponsored R&D projects and the Technology Transfer Program (TTP). The six appendices to this update provide information mandated by CTAC's role as the central counterdrug technology research and development organization of the U.S. Government. CTAC, in collaboration with the National Institute on Drug Abuse (NIDA), has sponsored the installation of advanced neuroimaging centers across the U.S. In Fiscal Year 2001, two advanced neuroimaging centers became operational at Emory University's 3 Tesla functional Magnetic Resonance Imaging (fMRI) system and at Massachusetts General Hospital (bringing the number of neuroimaging centers to ten). This expansion of the national infrastructure of advanced neuroimaging systems is enabling research into the underlying causes of substance abuse.
Office of National Drug Control Policy: http://www.whitehousedrugpolicy.gov/policy/ndcs.html